CN111388548A - 一种苦荞素片的配方及其制作工艺 - Google Patents
一种苦荞素片的配方及其制作工艺 Download PDFInfo
- Publication number
- CN111388548A CN111388548A CN202010266680.7A CN202010266680A CN111388548A CN 111388548 A CN111388548 A CN 111388548A CN 202010266680 A CN202010266680 A CN 202010266680A CN 111388548 A CN111388548 A CN 111388548A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- tartary buckwheat
- formula
- honeysuckle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 244000130270 Fagopyrum tataricum Species 0.000 title claims abstract description 52
- 235000014693 Fagopyrum tataricum Nutrition 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 238000009472 formulation Methods 0.000 title description 2
- 239000000284 extract Substances 0.000 claims abstract description 68
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 26
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 20
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 19
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 19
- 229920002472 Starch Polymers 0.000 claims abstract description 18
- 235000004298 Tamarindus indica Nutrition 0.000 claims abstract description 18
- 239000008107 starch Substances 0.000 claims abstract description 18
- 235000019698 starch Nutrition 0.000 claims abstract description 18
- 235000008584 Hovenia dulcis Nutrition 0.000 claims abstract description 17
- 244000010000 Hovenia dulcis Species 0.000 claims abstract description 17
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 13
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 13
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 13
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 13
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000811 xylitol Substances 0.000 claims abstract description 13
- 235000010447 xylitol Nutrition 0.000 claims abstract description 13
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 13
- 229960002675 xylitol Drugs 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 240000004584 Tamarindus indica Species 0.000 claims abstract 5
- 238000001035 drying Methods 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 6
- 235000009811 Momordica charantia Nutrition 0.000 claims description 5
- 244000078912 Trichosanthes cucumerina Species 0.000 claims description 5
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 239000011265 semifinished product Substances 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 210000004185 liver Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 230000035922 thirst Effects 0.000 abstract description 4
- 208000007848 Alcoholism Diseases 0.000 abstract description 3
- 206010067125 Liver injury Diseases 0.000 abstract description 3
- 201000007930 alcohol dependence Diseases 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 238000010791 quenching Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 210000001124 body fluid Anatomy 0.000 abstract description 2
- 239000010839 body fluid Substances 0.000 abstract description 2
- 230000007547 defect Effects 0.000 abstract description 2
- 231100000753 hepatic injury Toxicity 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 241000596504 Tamarindus Species 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 241000219051 Fagopyrum Species 0.000 description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 3
- 241000628997 Flos Species 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000439 acute liver injury Toxicity 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- -1 saponin compounds Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及一种苦荞素片的配方,所述配方包括如下重量份数的组分:苦荞提取物25‑35份、葛根提取物10‑20份、枳椇子提取物10‑20份、金银花提取物5‑15份、酸角提取物10‑20份、淀粉6‑10份、木糖醇2‑4份、羟丙基甲基纤维素2‑4份、硬脂酸镁1‑2份。本发明要解决的技术问题是,克服现有技术缺点,提供一种苦荞素片的配方及其制作工艺,通过苦荞提取物降血糖、血脂作用;葛根、枳椇子提取物的生津止渴、解酒毒、保护肝损伤作用,金银花提取物的清热解毒作用,科学合理的配伍使得该产品具有明显的降脂护肝作用。
Description
技术领域
本发明涉及苦荞素片技术领域,具体是指一种苦荞素片的配方及其制作工艺。
背景技术
苦荞,为蓼科一年生草本植物,是倍受人们亲睐的保健食品。《本草纲目》记载苦荞“味苦、平寒、有益气力、续精神、利耳目、宽胸、降气、健胃之功效。”现代研究表明,苦荞营养价值高,其中蛋白质含量约为干重的10%左右,主要有谷蛋白、水溶性清蛋白和盐溶性球蛋白组成,近似豆类蛋白;苦荞氨基酸含量高且配比适当,人体必需的8种氨基酸都含有,尤其富含精氨酸、赖氨酸、色氨酸、组氨酸等,对其它食物有很好的互补性。脂肪含量一般在2%至3%,含九种脂肪酸,人体易于吸收的油酸和亚油酸占苦荞脂肪酸的80%左右。苦荞中的无机盐含量丰富,硒、钾、镁、铜、铬、锌、钙、铁等含量都大大高于禾谷类作物,硒元素的存在有抗癌作用。苦荞富含维生素B族、维生素E等,独特之处就是含有大量黄酮类物质芦丁(即维生素P),占干重的2%以上,对人体有多种生理功能,能增强毛细血管的渗透性,改善心血管系统,抑制恶性肿瘤生长及癌症等。苦荞还含有较多的膳食纤维,尤其是胶质状葡聚糖,丰富的膳食纤维有排毒养颜的功能,对糖尿病和高血脂也有积极的调节作用。苦荞营养生理比价为73,是国际粮农组织公认的优秀粮药兼用粮种,是我国药食同源文化的典型体现。
现有市售苦荞素片,方便人取食,是以苦荞粉直接压片,没有进行有效成分提取,降脂减肥效果较差,同时现有的苦荞素片配方单一,作用机理单一,因此对现有的苦荞素片生产亟待改进。
发明内容
本发明要解决的技术问题是,克服现有技术缺点,提供一种苦荞素片的配方及其制作工艺,通过苦荞提取物降血糖、血脂作用;葛根、枳椇子提取物的生津止渴、解酒毒、保护肝损伤作用,金银花提取物的清热解毒作用,科学合理的配伍使得该产品具有明显的降脂护肝作用。
为解决上述技术问题,本发明提供的技术方案为:一种苦荞素片的配方,所述配方包括如下重量份数的组分:苦荞提取物25-35份、葛根提取物10-20份、枳椇子提取物10-20份、金银花提取物5-15份、酸角提取物10-20份、淀粉6-10份、木糖醇2-4份、羟丙基甲基纤维素2-4份、硬脂酸镁1-2份。
进一步的,配方包括如下重量份数的组分:苦荞提取物30份、葛根提取物15份、枳椇子提取物15份、金银花提取物10份、酸角提取物15份、淀粉8份、木糖醇3份、羟丙基甲基纤维素3份、硬脂酸镁1份。
一种苦荞素片的制作工艺,所述制作工艺包括如下操作步骤:
S1、原辅料的准备:准备足量的苦荞、葛根、枳椇子、金银花、酸角、淀粉、木糖醇、羟丙基甲基纤维素和硬脂酸镁;
S2、将配方量的苦荞、葛根、枳椇子、金银花、酸角混合后加入提取罐,加入6倍量的60%-70%的乙醇溶液常温常压浸泡12小时后,在压力0.06-0.07Mpa、温度60-70℃条件下反复提取3次,收集3次的提取液,浓缩得到相对应的浸膏;
S3,将浸膏置于干燥箱,温度80-90℃,干燥3-5小时;
S4、将初步干燥后的浸膏与配方量的淀粉通过高速混合制粒机进行制粒,然后在50-70℃温度下干燥;
S5、对干燥后的颗粒进行整粒,然后压片、包衣,得到苦瓜素片;
S6、将半成品分装、检测,成品入库。
本发明具有如下优点:
本发明的苦荞素片由药食同源的苦荞、金银花、葛根、枳椇子、酸角提取的有效成份组成,在传统的食用过程中,以上单品圴具有护肝养肝作用。其中苦荞提取物中的苦荞黄酮降血脂、降血糖、抗氧化的功效,有效地减轻肝脏负担及免受氧化作用的损害;金银花提取物中的绿原酸具有清热解毒、消炎的功效,起到保肝利胆的作用。葛根提取物中的葛根素含有皂苷类化合物,对肝组织免疫损害、急性肝损伤具有保护作用,能有效逆转化学诱导的肝纤维化。枳椇子解止渴除烦,清湿热,解酒毒功效,可保护酒精对肝的损伤。酸角提取物能补充人体所需的多种氨基酸及矿物质,具有止渴消热、消食、养肝明目功效。
1,本发明的产品中各成分均采用现代生物技术进行有效成分提取,效果明显,服用量减少。提取过程中还有效控制了该产品原药材中的重金属、微生物。
2,配方中的苦荞、葛根、枳椇子、金银花、酸角提取物具有很好的降血脂、解酒护肝、抗菌消炎的协同作用。
3,科学合理的配伍极大程度的提高了苦荞素片降脂护肝的靶向治疗作用。
具体实施方式
下面结合实施例对本发明做进一步的详细说明。
实施例1
本发明在具体实施时,一种苦荞素片的配方,所述配方包括如下重量份数的组分:苦荞提取物25份、葛根提取物10份、枳椇子提取物10份、金银花提取物5份、酸角提取物10份、淀粉6份、木糖醇2份、羟丙基甲基纤维素2份、硬脂酸镁1份。
一种苦荞素片的制作工艺,所述制作工艺包括如下操作步骤:
S1、原辅料的准备:准备足量的苦荞、葛根、枳椇子、金银花、酸角、淀粉、木糖醇、羟丙基甲基纤维素和硬脂酸镁;
S2、对苦荞、葛根、枳椇子、金银花、酸角混合后加入提取罐,加入6倍量的60%的乙醇溶液常温常压浸泡12小时后,在压力0.06Mpa、温度60℃条件下反复提取3次,收集3次的提取液,浓缩得到相对应的浸膏;
S3,将浸膏置于干燥箱,温度80℃,干燥3小时;
S4、将初步干燥后的浸膏与配方量的淀粉通过高速混合制粒机进行制粒,然后在50℃温度下干燥;
S5、对干燥后的颗粒进行整粒,然后压片、包衣,得到苦瓜素片;
S6、将半成品分装、检测,成品入库。
实施例2
本发明在具体实施时,一种苦荞素片的配方,所述配方包括如下重量份数的组分:苦荞提取物35份、葛根提取物20份、枳椇子提取物20份、金银花提取物15份、酸角提取物20份、淀粉10份、木糖醇4份、羟丙基甲基纤维素4份、硬脂酸镁2份。
一种苦荞素片的制作工艺,所述制作工艺包括如下操作步骤:
S1、原辅料的准备:准备足量的苦荞、葛根、枳椇子、金银花、酸角、淀粉、木糖醇、羟丙基甲基纤维素和硬脂酸镁;
S2、对苦荞、葛根、枳椇子、金银花、酸角混合后加入提取罐,加入6倍量的70%的乙醇溶液常温常压浸泡12小时后,在压力0.07Mpa、温度70℃条件下反复提取3次,收集3次的提取液,浓缩得到相对应的浸膏;
S3,将浸膏置于干燥箱,温度90℃,干燥3-5小时;
S4、将初步干燥后的浸膏与配方量的淀粉通过高速混合制粒机进行制粒,然后在70℃温度下干燥;
S5、对干燥后的颗粒进行整粒,然后压片、包衣,得到苦瓜素片;
S6、将半成品分装、检测,成品入库。
实施例3
本发明在具体实施时,一种苦荞素片的配方,所述配方包括如下重量份数的组分:苦荞提取物30份、葛根提取物15份、枳椇子提取物15份、金银花提取物10份、酸角提取物15份、淀粉8份、木糖醇3份、羟丙基甲基纤维素3份、硬脂酸镁1份。
一种苦荞素片的制作工艺,所述制作工艺包括如下操作步骤:
S1、原辅料的准备:准备足量的苦荞、葛根、枳椇子、金银花、酸角、淀粉、木糖醇、羟丙基甲基纤维素和硬脂酸镁;
S2、对苦荞、葛根、枳椇子、金银花、酸角混合后加入提取罐,加入6倍量的65%的乙醇溶液常温常压浸泡12小时后,在压力0.06Mpa、温度60-70℃条件下反复提取3次,收集3次的提取液,浓缩得到相对应的浸膏;
S3,将浸膏置于干燥箱,温度85℃,干燥4小时;
S4、将初步干燥后的浸膏与配方量的淀粉通过高速混合制粒机进行制粒,然后在60℃温度下干燥;
S5、对干燥后的颗粒进行整粒,然后压片、包衣,得到苦瓜素片;
S6、将半成品分装、检测,成品入库。
虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (3)
1.一种苦荞素片的配方,其特征在于,所述配方包括如下重量份数的组分:苦荞提取物25-35份、葛根提取物10-20份、枳椇子提取物10-20份、金银花提取物5-15份、酸角提取物10-20份、淀粉6-10份、木糖醇2-4份、羟丙基甲基纤维素2-4份、硬脂酸镁1-2份。
2.根据权利要求1所述的一种苦荞素片的配方,其特征在于,所述配方包括如下重量份数的组分:苦荞提取物30份、葛根提取物15份、枳椇子提取物15份、金银花提取物10份、酸角提取物15份、淀粉8份、木糖醇3份、羟丙基甲基纤维素3份、硬脂酸镁1份。
3.一种苦荞素片的制作工艺,其特征在于,所述制作工艺包括如下操作步骤:
S1、原辅料的准备:准备足量的苦荞、葛根、枳椇子、金银花、酸角、淀粉、木糖醇、羟丙基甲基纤维素和硬脂酸镁;
S2、将配方量的苦荞、葛根、枳椇子、金银花、酸角混合后加入提取罐,加入6倍量的60%-70%的乙醇溶液常温常压浸泡12小时后,在压力0.06-0.07Mpa、温度60-70℃条件下反复提取3次,收集3次的提取液,浓缩得到相对应的浸膏;
S3,将浸膏置于干燥箱,温度80-90℃,干燥3-5小时;
S4、将初步干燥后的浸膏与配方量的淀粉通过高速混合制粒机进行制粒,然后在50-70℃温度下干燥;
S5、对干燥后的颗粒进行整粒,然后压片、包衣,得到苦瓜素片;
S6、将半成品分装、检测,成品入库。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010266680.7A CN111388548A (zh) | 2020-04-07 | 2020-04-07 | 一种苦荞素片的配方及其制作工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010266680.7A CN111388548A (zh) | 2020-04-07 | 2020-04-07 | 一种苦荞素片的配方及其制作工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111388548A true CN111388548A (zh) | 2020-07-10 |
Family
ID=71411326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010266680.7A Withdrawn CN111388548A (zh) | 2020-04-07 | 2020-04-07 | 一种苦荞素片的配方及其制作工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111388548A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101518351A (zh) * | 2009-03-27 | 2009-09-02 | 武汉市久共合工贸有限公司 | 一种弱碱性植物解酒饮料及其制备方法 |
CN104206602A (zh) * | 2014-09-24 | 2014-12-17 | 李从国 | 一种高黄酮苦荞葛根配方茶及其制作方法 |
-
2020
- 2020-04-07 CN CN202010266680.7A patent/CN111388548A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101518351A (zh) * | 2009-03-27 | 2009-09-02 | 武汉市久共合工贸有限公司 | 一种弱碱性植物解酒饮料及其制备方法 |
CN104206602A (zh) * | 2014-09-24 | 2014-12-17 | 李从国 | 一种高黄酮苦荞葛根配方茶及其制作方法 |
Non-Patent Citations (1)
Title |
---|
李维熙等: "酸角的化学成分及生物活性研究现状", 《国际药学研究杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jan et al. | Nutritional constituents of mulberry and their potential applications in food and pharmaceuticals: A review | |
CN104351412B (zh) | 一种含黄蜀葵的复方保健茶 | |
CN104982599A (zh) | 一种植物凉茶浓缩液及低糖植物凉茶饮料 | |
CN103720903B (zh) | 一种抗炎清肺护肝茶及其制作方法 | |
KR101184666B1 (ko) | 양성 체질의 생리 활성 증진용 조성물 | |
CN102885186A (zh) | 一种沙棘凉茶及其制备工艺 | |
KR100771524B1 (ko) | 혼합 생약 추출물을 유효성분으로 함유하는 간 기능 개선용조성물 | |
CN112369609A (zh) | 一种能够降低尿酸的功能性食品及其制备方法 | |
KR101316091B1 (ko) | 황칠나무를 이용한 건강보조식품 및 이의 제조방법 | |
CN108813501B (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN102860394B (zh) | 养生护肝藤茶复合饮料及其制备方法 | |
CN103734767A (zh) | 一种保健食品 | |
CN114631632B (zh) | 一种护肝解酒的刺梨组合物及其制剂与应用 | |
CN104095269B (zh) | 一种纯天然接骨木籽果饮的制备 | |
KR101350046B1 (ko) | 항비만 효능을 갖는 복합 생약 발효 식초 조성물 및 그 제조방법 | |
CN111388548A (zh) | 一种苦荞素片的配方及其制作工艺 | |
KR20230090935A (ko) | 백출, 황기 및 방풍 추출물을 유효성분으로 포함하는 비염 예방 또는 치료용 조성물 | |
CN107080264A (zh) | 一种三高人群专用的松仁蛋白复合咀嚼片 | |
KR20150031373A (ko) | 비타민나무 잎 추출물을 유효성분으로 함유하는 비만 예방 또는 치료용 약학 조성물 및 식품 조성물 | |
CN107312692B (zh) | 一种金花葵苦荞酒的生产方法 | |
CN111743005A (zh) | 一种黑果花楸膳食纤维奶片及其制备方法 | |
KR20100089910A (ko) | 혼합 생약 추출물을 유효성분으로 함유하는 고지혈증 및 당뇨성 고지혈증의 예방 및 치료용 조성물 | |
KR102501508B1 (ko) | 생약 식물 추출물을 활용한 음료 또는 주류의 제조방법 | |
KR101003463B1 (ko) | 아토피성 피부염 억제효능을 갖는 청국장 환(丸)의 제조방법 | |
KR20170003153A (ko) | 천문동 추출물을 함유하는 호흡기 질환 예방 및 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200710 |
|
WW01 | Invention patent application withdrawn after publication |